Targeting cellular senescence as a therapeutic approach in non-alcoholic steatohepatitis

Ann Hepatol. 2023 Mar-Apr;28(2):100900. doi: 10.1016/j.aohep.2023.100900.

Authors

Yasuhiro Nakano¹, Yoshikazu Johmura²

Affiliations

¹ Department of Cancer and Senescence Biology, Cancer Research Institute, Kanazawa University, Kakuma, Kanazawa, Ishikawa 920-1192, Japan. Electronic address: johmuray@staff.kanazawa-u.ac.jp.
² Department of Cancer and Senescence Biology, Cancer Research Institute, Kanazawa University, Kakuma, Kanazawa, Ishikawa 920-1192, Japan. Electronic address: nakano@staff.kanazawa-u.ac.jp.

PMID: 36925209
DOI: 10.1016/j.aohep.2023.100900

No abstract available

MeSH terms

Cellular Senescence
Humans
Non-alcoholic Fatty Liver Disease* / diagnosis
Non-alcoholic Fatty Liver Disease* / drug therapy